DEC 17, 2018 3:11 PM PST

Nanocapsules Improve The Delivery of Antiparasitic Drugs

WRITTEN BY: Nouran Amin

The efficacy of antiparasitic medications highly depends on how they dissolve and are absorbed by the body—limiting the therapeutic potential of traditionally insoluble anti-parasitic drugs.

The chemical structure of Triclabendazole used to treat flatworm infections.

Credit: PLOS

Now, an international team has sought ways to conquer this challenge by developing a new pharmaceutical formula using nanotechnology and nanomedicine approaches. The novel formula will specifically be used to administer the anti-parasitic drug—triclabendazole.

Triclabendazole is used to treat fascioliasis which is an infectious disease caused by flatworms. According to the World Health Organization, an estimated 2.4 million people are infected with fascioliasis. The disease is considered ‘neglected’ because it receives little to no attention and often goes undiagnosed.

Learn more about parasitic infections:

The new formula produces nanocapsules, less than a micron in size, to be loaded with triclabendazole and then bundled together for effective delivery. To bind the drug and coat the oil-core of capsules, researchers used a natural sugar polymer present in the exoskeleton of shellfish as well as the cell walls of some fungi. This polymer is called ‘chitosan’ and will specifically help stabilize the capsule and preserve the drug.

In the nanocapsule from, the drug would be 100 times more soluble than the current tablet form.

"Solubility is a critical challenge for effective anti-parasite medicine. We looked to tackle this problem at the particle level. Triclabendazole taken as a dose made up of billions of tiny capsules would mean the medicine would be more efficiently and quickly absorbed,” explains Professor Goycoolea, from the School of Food Science and Nutrition at the University of Leeds. "Through the use of nanocapsules and nanoemulsions, drug efficiency can be enhanced and new solutions can be considered for the best ways to target medicine delivery."

Source: PLOS ONE

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 14, 2021
Cancer
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
OCT 14, 2021
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
Colorectal cancer develops when a series of changes occur across multiple genes.  While researchers have paid signi ...
OCT 18, 2021
Health & Medicine
Emerging Research on Delta 8 THC
OCT 18, 2021
Emerging Research on Delta 8 THC
Delta-8-tetrahydrocannabinol is a cannabinoid derived from the hemp plant. It is one of the more prominent compounds, bu ...
OCT 20, 2021
Microbiology
Bacteria From Cats Could Help Treat Infections
OCT 20, 2021
Bacteria From Cats Could Help Treat Infections
Many animals, including humans and cats, harbor huge colonies of microbes, which may live in places like the skin, or th ...
OCT 26, 2021
Genetics & Genomics
In a First, Bach1 Protein Linked to Parkinson's, Revealing Potential Treatment
OCT 26, 2021
In a First, Bach1 Protein Linked to Parkinson's, Revealing Potential Treatment
One of the most common neurodegenerative disorders is Parkinson's disease, impacting an estimated 10 million people arou ...
OCT 27, 2021
Cardiology
Are Certain Anti-inflammatory Agents an Effective Treatment for Heart Disease?
OCT 27, 2021
Are Certain Anti-inflammatory Agents an Effective Treatment for Heart Disease?
Worldwide, heart disease is responsible for millions of deaths and, in the US, is the most common cause of death de ...
NOV 12, 2021
Cannabis Sciences
Battle of the Cannabinoids: Which Cannabis Compound Could Most Effectively Treat IBD?
NOV 12, 2021
Battle of the Cannabinoids: Which Cannabis Compound Could Most Effectively Treat IBD?
With 3 million people from the U.S. reporting clinical cases in 2015 – accompanied by an increased projected incid ...
Loading Comments...